Half-year report · Q2
3141.TEDINET S100WSXP
Period2025-03-01 → 2025-08-31
Filed2025-10-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥678.8bn | 2025-03-01 → 2025-08-31 | Cons. | Net sales |
| Revenue | ¥1.29T | 2024-03-01 → 2025-02-28 | Cons. | Net sales (5-year summary) |
| Revenue | ¥630.6bn | 2024-03-01 → 2024-08-31 | Cons. | Net sales |
| Operating income | ¥22.8bn | 2025-03-01 → 2025-08-31 | Cons. | Operating income |
| Operating income | ¥18.9bn | 2024-03-01 → 2024-08-31 | Cons. | Operating income |
| Ordinary income | ¥25.4bn | 2025-03-01 → 2025-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥40.8bn | 2024-03-01 → 2025-02-28 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥20.9bn | 2024-03-01 → 2024-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥25.0bn | 2025-03-01 → 2025-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥20.6bn | 2024-03-01 → 2024-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥15.9bn | 2025-03-01 → 2025-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥15.0bn | 2024-03-01 → 2025-02-28 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥11.7bn | 2024-03-01 → 2024-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥16.1bn | 2025-03-01 → 2025-08-31 | Cons. | Profit loss |
| Net income | ¥11.5bn | 2024-03-01 → 2024-08-31 | Cons. | Profit loss |
| Total assets | ¥649.6bn | at 2025-08-31 | Cons. | Assets |
| Total assets | ¥580.0bn | at 2025-02-28 | Cons. | Assets |
| Total assets | ¥621.0bn | at 2024-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥381.5bn | at 2025-08-31 | Cons. | Liabilities |
| Total liabilities | ¥325.5bn | at 2025-02-28 | Cons. | Liabilities |
| Net assets / equity | ¥268.1bn | at 2025-08-31 | Cons. | Net assets |
| Net assets / equity | ¥254.5bn | at 2025-02-28 | Cons. | Net assets |
| Net assets / equity | ¥253.9bn | at 2024-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥91.5bn | at 2025-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥35.0bn | at 2025-02-28 | Cons. | Cash and deposits |
| Cash & equivalents | ¥90.9bn | at 2025-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥34.4bn | at 2025-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥82.2bn | at 2024-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥30.1bn | at 2024-02-29v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥81.4bn | 2025-03-01 → 2025-08-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥47.8bn | 2024-03-01 → 2025-02-28 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥71.4bn | 2024-03-01 → 2024-08-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥6.9bn | 2025-03-01 → 2025-08-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥22.7bn | 2024-03-01 → 2025-02-28 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.0bn | 2024-03-01 → 2024-08-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥18.0bn | 2025-03-01 → 2025-08-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥20.8bn | 2024-03-01 → 2025-02-28 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥15.3bn | 2024-03-01 → 2024-08-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥76.62 | 2025-03-01 → 2025-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥72.23 | 2024-03-01 → 2025-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥56.65 | 2024-03-01 → 2024-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥76.6 | 2025-03-01 → 2025-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥72.18 | 2024-03-01 → 2025-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥56.61 | 2024-03-01 → 2024-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 40.4% | at 2025-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.8% | at 2025-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.8% | at 2024-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 505
| Item | Context | Value | Unit |
|---|---|---|---|
| Description of fact that companys business comprises single segment | CurrentYTDDuration | Original text (Japanese)当社グループは、医薬品・調剤・化粧品等を中心とした小売事業の単一セグメントであるため、記載を省略しております。 | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |